心电射频消融术在急性冠状动脉综合征伴频发性室性早搏患者复律治疗中的应用观察  

Application of cardiac radiofrequency ablation in restoration of sinus rhythm in patients with acute coronary syndrome and frequent ventricular premature beat

作　　者：言纬 潘兴寿[1] 李近都 邹才华[3] 梁烨[4] 李天资[1] 曾德创[5] 陆荣臻[6] YAN Wei;PAN Xingshou;LI Jindu;ZOU Caihua;LIANG Ye;LI Tianzi;ZENG Dechuang;LU Rongzhen(Cardiovascular Medicine Department,Affiliated Hospital of Youjiang Medical University for Nationalities,Baise 533000,China;不详)

机构地区：[1]右江民族医学院附属医院心血管内科,广西百色533000 [2]广西医科大学附属肿瘤医院肝胆外科 [3]右江民族医学院附属医院腺体外科 [4]右江民族医学院附属医院教学部 [5]右江民族医学院附属医院心胸外科 [6]右江民族医学院附属医院麻醉科

出　　处：《山东医药》2023年第5期23-26,共4页Shandong Medical Journal

基　　金：广西自然科学基金项目(2019JJA140159);广西中青年教师基础能力提升基金项目(2020KY13013)。

摘　　要：目的观察心电射频消融术(CRA)在急性冠状动脉综合征(ACS)伴频发性室性早搏(FVPB)患者复律治疗中的应用效果。方法选取ACS伴FVPB患者80例,随机分为CRA组、药物治疗组各40例。CRA组采用CRA进行复律治疗,药物治疗组采用胺碘酮+利多卡因+β受体阻滞剂的常规药物复律治疗,比较两组患者治疗前后室性早搏频次及血浆白细胞分化抗原40配体(CD40L)、白细胞介素1β(IL-1β)水平。结果两组治疗前室性早搏频率差异无统计学意义,CRA组治疗后室性早搏频率低于药物治疗组(P<0.05)。两组治疗前血浆CD40L、IL-1β差异无统计学意义;CRA组治疗后血浆CD40L、IL-1β低于药物治疗组(P均<0.05)。结论心电射频消融术用于ACS伴FVPB的患者复律治疗,可有效降低患者室性早搏频率,并降低患者血浆CD40L及IL-1β水平。Objective To investigate the application effect of cardiac radiofrequency ablation(CRA)in restoration of sinus rhythm of patients with acute coronary syndrome(ACS)and frequent ventricular premature beat(FVPB).Methods Eighty ACS patients with FVPB were randomly divided into CRA group(n=40)and drug treatment group(n=40).Patients in the CRA group were treated with CRA while patients in the drug treatment group were treated with amiodarone+lidocaine+β-blocker.The frequency of ventricular extrasystole and the levels of plasma leukocyte differentiation antigen 40 ligand(CD40L)and interleukin-1β(IL-1β)were compared between the two groups before and after treatment.Results There was no significant difference in the frequency of premature ventricular beats between the two groups before treatment.After treatment,the frequency of premature ventricular beats in the CRA group was lower than that in drug treatment group(P<0.05).There were no significant differences in plasma CD40L or IL-1βbetween the two groups before treatment.Plasma CD40L and IL-1βin the CRA group after treatment were lower than those in the drug treatment group(both P<0.05).Conclusion CRA can effectively reduce the frequency of ventricular premature beats and plasma CD40L and IL-1βlevels in ACS patients with FVPB.

关 键 词：急性冠状动脉综合征 频发性室性早搏 心电射频消融术 电生理标测 心脏复律 

分 类 号：R541.4[医药卫生—心血管疾病]